## CNC: Centene Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 0.5% below STRENGTH zone (3.0-6.0%); PEG 1.64 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.96)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Brighton Jones LLC Boosts Stake in Centene Corporation $CNC**
- Source: MarketBeat | 20251225T050738 | Neutral | Relevance: 100%
- Brighton Jones LLC significantly increased its stake in Centene Corporation (NYSE:CNC) by 143.7% in Q3, now holding 49,174 shares worth $1.76 million. This comes as Centene surpassed Q3 earnings expectations with an EPS of $0.50 and revenue of $49.69 billion. Despite the positive earnings, the company posted a negative net margin of 2.85%, and analysts currently rate the stock as a "Hold" with an average target price of $38.44.

**2. Elevance Health, Inc. $ELV Shares Bought by Hunter Perkins Capital Management LLC**
- Source: MarketBeat | 20251225T115902 | Somewhat-Bearish | Relevance: 73%
- Hunter Perkins Capital Management LLC significantly increased its stake in Elevance Health, Inc. (NYSE:ELV), boosting its holdings by 34.4% to 20,581 shares valued at approximately $6.65 million. This makes Elevance Health the firm's 22nd largest holding. Elevance Health has received a "Moderate Buy" consensus rating from analysts, with an average target price of $396.21, and recently reported strong Q3 earnings, surpassing revenue and EPS expectations.

**3. Molina Healthcare, Inc $MOH Shares Purchased by Swedbank AB**
- Source: MarketBeat | 20251227T110828 | Neutral | Relevance: 63%
- Swedbank AB increased its holdings in Molina Healthcare, Inc (MOH) by 8.2% in the third quarter, acquiring an additional 8,416 shares to own a total of 110,592 shares valued at approximately $21.16 million. Despite institutional investors owning 98.5% of the stock, analysts have a "Hold" rating with an average price target of $196.33, after the company reported a significant quarterly EPS miss and provided lower-than-expected FY2025 guidance.

**4. ZWJ Investment Counsel Inc. Reduces Stake in Elevance Health, Inc. $ELV**
- Source: MarketBeat | 20251225T133559 | Neutral | Relevance: 63%
- ZWJ Investment Counsel Inc. has reduced its stake in Elevance Health, Inc. by 23.5% in the third quarter of 2025, selling 29,145 shares and retaining 94,986 shares valued at $30.7 million. Despite this reduction, Elevance Health exceeded Q3 expectations with an EPS of $6.03 and revenues of $50.09 billion, and institutional investors collectively own 89.24% of the stock. Analysts have a "Moderate Buy" consensus rating with an average target price of $396.21.

**5. Cwm LLC Purchases 59,690 Shares of Molina Healthcare, Inc $MOH**
- Source: MarketBeat | 20251228T090534 | Neutral | Relevance: 63%
- Cwm LLC significantly increased its stake in Molina Healthcare (NYSE:MOH) by 364.9%, acquiring 59,690 additional shares to own a total of 76,049 shares valued at approximately $14.55 million. This move comes as Molina Healthcare reported a quarterly EPS miss but an 11% revenue increase, with analysts maintaining a "Hold" rating and an average price target of $196.33 for the stock.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.00M) |
| Sells | 2 ($2.58M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.6% (-2.8%)
- Blackrock Inc.: 9.2% (+0.3%)
- State Street Corpora: 4.3% (-7.7%)
- AQR Capital Manageme: 3.0% (+76.6%)
- Geode Capital Manage: 2.6% (-4.8%)

### Key Risks

1. Long-term trend broken: trading 5.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +1.2% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.64 elevated, pricing in significant growth expectations. Forward P/E 14.0x attractive for 43% earnings growth. Balance sheet: $1.1B free cash flow. Insider selling cluster ($2.6M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.9B |
| Beta | 0.48 |
| 52W Range | $25.08 - $66.81 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.64 |
| Forward P/E | 14.0 |
| Current P/E | 20.0 |
| YoY Growth | 43.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -0.7% to 0.5% (+1.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.5pp (needs >3.0% for momentum thesis). MRS_5 at 1.4% confirms short-term momentum alignment. Below SMA200 (0.94x), long-term trend not supportive. OFD pattern: +FTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.51% (CS: 83) | Neutral |
| RSI_14 | 60.6 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 1.033x | Above |
| vs SMA50 | 1.086x | Above |
| vs SMA200 | 0.941x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $40.52
- **Stop Loss:** $37.96 (6.3% risk)
- **Target:** $43.08 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 515
- **Position Value:** $20,867.80
- **Portfolio %:** 20.87%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-03 (Est: $-1.19)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.16 | $0.50 | +404.3% |
| 2025Q2 | $0.21 | $-0.16 | -177.3% |
| 2025Q1 | $2.52 | $2.90 | +15.3% |
| 2024Q4 | $0.49 | $0.80 | +62.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*